Drugs A - Z

lomustine Images

Generic Name: lomustine

Brand Names: Ceenu

There is an FDA Alert for this drug. Click here to view it.

  • Use under supervision of a qualified clinician experienced in therapy with antineoplastic agents.
  • Risk of bone marrow suppression (e.g., thrombocytopenia, leukopenia), resulting in bleeding and infection. Bone marrow toxicity is delayed and cumulative. Monitor CBCs weekly during and for at least 6 weeks following each dose; do not administer more frequently than every 6 weeks. Adjust subsequent dosages based on nadir blood counts from previous dose. (See Dosage Modification for Toxicity under Dosage and Administration.)

The Healthline Site, its content, such as text, graphics, images, search results, HealthMaps, Trust Marks, and other material contained on the Healthline Site ("Content"), its services, and any information or material posted on the Healthline Site by third parties are provided for informational purposes only. None of the foregoing is a substitute for professional medical advice, examination, diagnosis, or treatment. Always seek the advice of a physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the Healthline Site. If you think you may have a medical emergency, call your doctor or 911 immediately. Please read the Terms of Service for more information regarding use of the Healthline Site.
Advertisement